Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
B 138.66 -0.29% -0.40
NVO closed up 0.7 percent on Monday, January 30, 2023, on approximately normal volume.
Earnings due: Feb 1
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction -0.29%
Multiple of Ten Bearish Other -0.29%
Gapped Up Strength -0.29%
1,2,3 Pullback Bullish Bullish Swing Setup 0.41%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.41%
Bollinger Band Squeeze Range Contraction 0.41%
Inside Day Range Contraction 0.41%
20 DMA Support Bullish 0.81%
Bollinger Band Squeeze Range Contraction 0.81%
BB Squeeze Started Range Contraction 0.81%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 31 minutes ago
20 DMA Support about 5 hours ago
2x Volume Pace about 6 hours ago
1.5x Volume Pace about 6 hours ago
Down 1 ATR about 6 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novo Nordisk A/S Description

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Diabetes Pharmaceutical Products Inflammation Insulin Endocrine System Obesity Hormones Peptide Hormones Growth Hormone Glucagon Like Peptide 1 Diabetes Care Growth Hormone Therapy Haemophilia Pharmaceuticals Segment Anti Diabetic Drugs Hormone Therapy Related Delivery Systems

Is NVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 144.78
52 Week Low 94.75
Average Volume 1,354,359
200-Day Moving Average 114.01
50-Day Moving Average 130.83
20-Day Moving Average 137.62
10-Day Moving Average 139.51
Average True Range 2.48
RSI 60.63
ADX 38.07
+DI 37.80
-DI 18.18
Chandelier Exit (Long, 3 ATRs) 137.35
Chandelier Exit (Short, 3 ATRs) 137.53
Upper Bollinger Bands 142.46
Lower Bollinger Band 132.78
Percent B (%b) 0.65
BandWidth 7.03
MACD Line 2.34
MACD Signal Line 2.81
MACD Histogram -0.4696
Fundamentals Value
Market Cap 321.84 Billion
Num Shares 2.31 Billion
EPS 2.46
Price-to-Earnings (P/E) Ratio 56.48
Price-to-Sales 7.68
Price-to-Book 16.16
PEG Ratio 2.82
Dividend 1.04
Dividend Yield 0.75%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 141.97
Resistance 3 (R3) 142.22 141.49 141.49
Resistance 2 (R2) 141.49 140.75 141.37 141.32
Resistance 1 (R1) 140.28 140.29 139.92 140.03 141.16
Pivot Point 139.55 139.55 139.37 139.43 139.55
Support 1 (S1) 138.34 138.81 137.98 138.09 136.96
Support 2 (S2) 137.61 138.35 137.49 136.80
Support 3 (S3) 136.40 137.61 136.64
Support 4 (S4) 136.15